Clinical Trials
5
Active:0
Completed:2
Trial Phases
3 Phases
Phase 1:2
Phase 2:1
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (40.0%)Phase 1
2 (40.0%)Phase 2
1 (20.0%)A Randomized, Double-blind Study to Evaluate the Clinical Effect and Safety of Fucoidan in Patients With Squamous Cell Carcinomas of the Head and Neck
Phase 2
Recruiting
- Conditions
- Squamous Cell Carcinomas of the Head and Neck
- First Posted Date
- 2020-10-22
- Last Posted Date
- 2024-03-05
- Lead Sponsor
- Hi-Q Marine Biotech International, Ltd.
- Target Recruit Count
- 119
- Registration Number
- NCT04597476
- Locations
- 🇨🇳
National Taiwan University Hospital, Taipei county, Taiwan
Study of Oligo-Fucoidan in Advanced Hepatocellular Carcinoma (HCC)
Not Applicable
Terminated
- Conditions
- Advanced Hepatocellular Carcinoma
- First Posted Date
- 2019-08-26
- Last Posted Date
- 2025-01-13
- Lead Sponsor
- Hi-Q Marine Biotech International, Ltd.
- Target Recruit Count
- 87
- Registration Number
- NCT04066660
- Locations
- 🇨🇳
Fudan University Zhongshan Hospital, Shanghai, China
To Evaluate the QoL Improvement of Oral Oligo Fucoidan in Subjects Receiving Platinum-based Chemotherapy With NSCLC
Not Applicable
Withdrawn
- Conditions
- NSCLC Stage IVNSCLC, Stage III
- First Posted Date
- 2017-04-27
- Last Posted Date
- 2019-08-28
- Lead Sponsor
- Hi-Q Marine Biotech International, Ltd.
- Registration Number
- NCT03130829
- Locations
- 🇨🇳
Shuang Ho Hospital, New Taipei City, Taiwan
🇨🇳Wan-Fang Hospital, Taipei, Taiwan
🇨🇳Taipei Medical University Hospital, Taipei, Taiwan
News
No news found